Mini- Vs. Regular-Dose CLAG-M (Cladribine, Cytarabine, G-CSF, and Mitoxantrone) in Medically Less Fit Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and Other High-Grade Myeloid Neoplasms

被引：3
|
作者：
Halpern, Anna B. [1 ,2 ]
Othus, Megan [3 ]
Gardner, Kelda [1 ]
Alcorn, Genevieve [4 ]
Percival, Mary-Elizabeth M. [1 ,2 ]
Huebner, Emily M. [2 ]
Scott, Bart L. [1 ,2 ]
Becker, Pamela S. [2 ,5 ]
Hendrie, Paul C. [1 ]
Oehler, Vivian G. [2 ]
Estey, Elihu H. [1 ,2 ]
Walter, Roland B. [1 ,2 ]
机构：
[1] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA
[2] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[3] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[4] Univ Washington, Dept Med, Div Hematol, Ctr Med, Seattle, WA 98195 USA
[5] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-123542
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1364
引用
收藏
页数：4
相关论文
共 20 条
  • [1] Phase 1 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm
    Godwin, Colin D.
    Othus, Megan
    Percival, Mary-Elizabeth M.
    Scott, Bart L.
    Becker, Pamela S.
    Gardner, Kelda M.
    Keel, Sioban B.
    Dhawale, Tejaswini M.
    Oehler, Vivian G.
    Abkowitz, Janis L.
    Halpern, Anna B.
    Hendrie, Paul C.
    Orlowski, Kaysey F.
    Woo, Alice
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2019, 134
  • [2] Phase I Trial Combining Venetoclax with Cladribine, Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) for Patients with Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms
    Raychaudhuri, Suravi
    Gooley, Ted
    Rasmussen, Allegra
    Quach, Kim
    Gill, Zach
    Halpern, Anna B.
    Appelbaum, Jacob S.
    Ghiuzeli, Cristina Maria
    Hendrie, Paul C.
    Cassaday, Ryan D.
    Walter, Roland B.
    Estey, Elihu
    Percival, Mary-Elizabeth M.
    BLOOD, 2024, 144 : 4288 - 4289
  • [3] A Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, G-CSF, and Dose-Escalated Mitoxantrone (CLAG-M) Plus Gemtuzumab Ozogamicin in Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) or Other High-Grade Myeloid Neoplasm
    Godwin, Colin D.
    Othus, Megan
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Scott, Bart L.
    Appelbaum, Jacob S.
    Halpern, Anna B.
    Oehler, Vivian G.
    Orozco, Johnnie J.
    Keel, Sioban B.
    Abkowitz, Janis L.
    Cooper, Jason P.
    Cassaday, Ryan D.
    Orlowski, Kaysey F.
    Marshall, Anise J.
    Brown, Clarisa N.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2021, 138
  • [4] Randomized phase 1 study of sequential ("primed") vs. concurrent decitabine in combination with cladribine, cytarabine, G-CSF, and mitoxantrone (CLAG-M) in adults with newly diagnosed or relapsed/refractory acute myeloid leukemia (AML) or other high-grade myeloid neoplasm
    Palmieri, Raffaele
    Buckley, Sarah A.
    Othus, Megan
    Halpern, Anna B.
    Percival, Mary-Elizabeth M.
    Scott, Bart L.
    Hendrie, Paul C.
    Becker, Pamela S.
    Oehler, Vivian G.
    Estey, Elihu H.
    Walter, Roland B.
    LEUKEMIA & LYMPHOMA, 2020, 61 (07) : 1728 - 1731
  • [5] Phase I Trial Combining Venetoclax with G-CSF, Cladribine, Cytarabine, and Mitoxantrone (CLAG-M) for Patients with High-Grade Myeloid Neoplasms
    Raychaudhuri, Suravi
    Gooley, Ted
    Gill, Zach
    Rasmussen, Allegra
    Halpern, Anna B.
    Appelbaum, Jacob S.
    Ghiuzeli, Cristina Maria
    Hendrie, Paul C.
    Cassaday, Ryan D.
    Walter, Roland B.
    Estey, Elihu
    Percival, Mary-Elizabeth M.
    BLOOD, 2023, 142
  • [6] Addition of Sorafenib to Cladribine, High-Dose Cytarabine, G-CSF, and Mitoxantrone (CLAG-M) in Adults with NewlyDiagnosed Acute Myeloid Leukemia (AML) and High-Grade Myeloid Neoplasms Independent of FLT3-Mutation Status: Final Results of a Phase 1/2 Study
    Halpern, Anna B.
    Rodriguez-Arboli, Eduardo P.
    Othus, Megan
    Garcia, Kelsey-Leigh A.
    Percival, Mary-Elizabeth M.
    Cassaday, Ryan D.
    Oehler, Vivian G.
    Becker, Pamela S.
    Appelbaum, Jacob S.
    Abkowitz, Janis L.
    Orozco, Johnnie J.
    Keel, Sioban B.
    Hendrie, Paul C.
    Scott, Bart L.
    Ghiuzeli, Cristina
    Walter, Roland B.
    Estey, Elihu H.
    BLOOD, 2022, 140 : 8999 - 9001
  • [7] Phase I/II trial of cladribine, high-dose cytarabine, mitoxantrone, and G-CSF with dose-escalated mitoxantrone for relapsed/refractory acute myeloid leukemia and other high-grade myeloid neoplasms
    Halpern, Anna B.
    Othus, Megan
    Huebner, Emily M.
    Scott, Bart L.
    Hendrie, Paul C.
    Percival, Mary-Elizabeth M.
    Becker, Pamela S.
    Smith, Heather A.
    Oehler, Vivian G.
    Orozco, Johnnie J.
    Cassaday, Ryan D.
    Gardner, Kelda M.
    Chen, Tara L.
    Buckley, Sarah A.
    Orlowski, Kaysey F.
    Anwar, Asma
    Estey, Elihu H.
    Walter, Roland B.
    HAEMATOLOGICA, 2019, 104 (04) : E143 - E146
  • [8] Phase 1/2 Trial of CLAG-M with Dose-Escalated Mitoxantrone in Combination with Fractionated-Dose Gemtuzumab Ozogamicin for Newly Diagnosed Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
    Godwin, Colin D.
    Rodriguez-Arboli, Eduardo
    Othus, Megan
    Halpern, Anna B.
    Appelbaum, Jacob S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Oehler, Vivian G.
    Keel, Sioban B.
    Abkowitz, Janis L.
    Cooper, Jason P.
    Cassaday, Ryan D.
    Estey, Elihu H.
    Walter, Roland B.
    CANCERS, 2022, 14 (12)
  • [9] G-CSF, Cladribine, Cytarabine, and Dose-Escalated Mitoxantrone (GCLAM) in Adults with Relapsed/Refractory Acute Myeloid Leukemia (AML) or High-Grade Myeloid Neoplasms: Final Results from a Phase 1/2 Trial
    Halpern, Anna B.
    Huebner, Emily M.
    Othus, Megan
    Scott, Bart L.
    Becker, Pamela S.
    Percival, Mary-Elizabeth M.
    Hendrie, Paul C.
    Gardner, Kelda M.
    Buckley, Sarah A.
    Estey, Elihu H.
    Walter, Roland B.
    BLOOD, 2017, 130
  • [10] The combination of cladribine with cytarabine and G-CSF (CLAG) or CLAG with mitoxantrone (CLAG-M) as induction therapy in primary resistant or relapsed acute myeloid leukemia - Polish Adult Leukemia Group (PALG) study.
    Robak, T
    Wrzesien-Kus, A
    Lech-Maranda, E
    Wierzbowska, A
    Sobczak-Pluta, A
    Holowiecki, J
    Kyrcz-Krzemien, S
    Grosicki, S
    Kuliczkowski, K
    Dmoszynska, A
    Kowal, M
    Hellmann, A
    Maj, S
    BLOOD, 2003, 102 (11) : 250B - 250B
12